BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin Y, Hou C, Li Y, Zheng K, Wang C. mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2. Front Immunol 2022;12:821538. [DOI: 10.3389/fimmu.2021.821538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Taddeo A, Veiga IB, Devisme C, Boss R, Plattet P, Weigang S, Kochs G, Thiel V, Benarafa C, Zimmer G. Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2. npj Vaccines 2022;7. [DOI: 10.1038/s41541-022-00508-7] [Reference Citation Analysis]
2 Labarrere CA, Kassab GS. Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease. Front Microbiol 2022;13:979719. [DOI: 10.3389/fmicb.2022.979719] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mori K, Mori T, Nagata T, Ando H, Hino A, Tateishi S, Tsuji M, Muramatsu K, Fujino Y. COVID-19 vaccination coverage by company size and the effects of workplace vaccination program in Japan: a cohort study. Environ Health Prev Med 2022;27:29. [PMID: 35786684 DOI: 10.1265/ehpm.22-00091] [Reference Citation Analysis]
4 Sun YS, Xia Y, Xu F, Lu HJ, Mao ZA, Gao M, Pan TY, Yao PP, Wang Z, Zhu HP. Development and evaluation of an inactivated Coxsackievirus A16 vaccine in gerbils. Emerg Microbes Infect 2022;:1-39. [PMID: 35787233 DOI: 10.1080/22221751.2022.2093132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Taddeo A, Veiga IB, Devisme C, Boss R, Plattet P, Weigang S, Kochs G, Thiel V, Benarafa C, Zimmer G. Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior protective humoral immune response to SARS-CoV-2.. [DOI: 10.1101/2022.06.14.495413] [Reference Citation Analysis]
6 Isaguliants M, Burt FJ. Perspective Technologies of Vaccination: Do We Still Need Old Vaccines? Vaccines 2022;10:891. [DOI: 10.3390/vaccines10060891] [Reference Citation Analysis]
7 Mori K, Mori T, Nagata T, Ando H, Hino A, Tateishi S, Tsuji M, Muramatsu K, Fujino Y, the CORoNa Work Project. COVID-19 vaccination coverage by company size and the effects of socioeconomic factors and workplace vaccination in Japan: a cohort study.. [DOI: 10.1101/2022.03.30.22273203] [Reference Citation Analysis]